Navigation Links
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
Date:2/19/2008

Pamela Harris appointed to lead Diabetes Sales, Managed Care and Government

Accounts on national level

PRINCETON, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Novo Nordisk, a healthcare company with an 85-year history of innovation and achievement in diabetes care, today announced the company has appointed Pamela Harris as vice president for Diabetes Sales, Managed Care and Government Accounts, effective immediately.

Harris, who since 2005 shared responsibility for managing the diabetes field force, will assume an expanded role of leading the company's 2,000-person field organization of representatives and managed market account executives.

"Pam has developed an impressive and successful track record in sales, managed healthcare, training and marketing," said Jerzy Gruhn, president of Novo Nordisk, Inc. "Her leadership style and strong business experience will help us continue to grow our company and help change the lives of millions of people living with diabetes."

Harris joined Novo Nordisk in 2005 after leading one of the national sales teams at Novartis Pharmaceuticals. In her 28 years in the pharmaceutical industry, she has held various positions in sales leadership roles, training, and marketing. Harris has received several awards recognizing her achievements. At Bristol-Myers Squibb, she was recognized for outstanding leadership and selected from 800 nominees worldwide to receive the Bristol-Myers Squibb Leadership Development Award. Additionally, she has been honored by the Harlem YWCA and was the recipient of their Black Achiever in Industry Award.

Harris received a Bachelor's degree from the College of New Jersey (formerly Trenton State College).

About Novo Nordisk

Novo Nordisk is a healthcare company with an 85-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 26,000 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Novo Nordisk Appoints New Leader of North American Business
2. Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes
3. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
4. Novo Nordisk Increased Net Profit by 32% in 2007
5. Novo Nordisk Files Annual Report with the SEC
6. Adverse housing conditions contribute to diabetes risk
7. RAND finds cases of undiagnosed diabetes drop sharply
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Diabetes appears to increase risk of death for patients with acute coronary syndromes
10. Discovery of sugar sensor in intestine could benefit diabetes
11. Despite overeating, morbidly obese mice gain protection against diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent ... as the number one company for hearing aids, ranking it ... fifteen other brands. ... Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, ...
Breaking Medicine Technology: